From: Development and feasibility of randomized trial to reduce urinary bisphenols in women with obesity
 | Control (N = 15) | Intervention (N = 15) | ||
---|---|---|---|---|
Study entry GM (95% CI) | 3 weeks GM (95% CI) | Study entry GM (95% CI) | 3 weeks GM (95% CI) | |
BPA, μg/g creatinine | 0.19 (− 0.21, 1.27) | 0.24 (0.08, 1.03) | 0.32 (0.25,1.55) | 0.32 (0.19, 1.15) |
BPS, μg/g creatinine | 0.73 (0.58, 2.34) | 0.64 (0.86, 2.06) | 2.31 (2.03, 3.81) | 1.04 (0.69, 1.89) |
BPF, μg/g creatinine | 0.13 (− 4.55, 3.98) | 0.12 (− 0.14, 2.41) | 0.79 (1.73, 10.25) | 0.24 (− 0.54, 2.01) |